Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS: ACUR · Delayed Price · USD
0.0025
0.00 (0.00%)
Mar 26, 2024, 10:36 AM EDT - Market closed
Acura Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1984 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 1.56 | 3.57 | 2.66 | 0.41 | 2.97 | 4.46 | 8.59 | 0.75 | 0.12 | Upgrade
|
Revenue Growth (YoY) | - | -56.22% | 34.36% | 548.05% | -86.18% | -33.56% | -48.01% | 1043.41% | 510.57% | - | Upgrade
|
Cost of Revenue | 0 | 1.21 | 0 | 0 | 0 | 0.13 | 0.45 | 0.66 | 0.23 | 0.11 | Upgrade
|
Gross Profit | 0 | 0.35 | 3.57 | 2.66 | 0.41 | 2.84 | 4.01 | 7.93 | 0.52 | 0.01 | Upgrade
|
Selling, General & Admin | 0 | 1.25 | 2.55 | 1.88 | 2.57 | 4.34 | 6.52 | 8.99 | 7.94 | 8.93 | Upgrade
|
Research & Development | 0 | 1.52 | 1.78 | 1.51 | 1.76 | 3.72 | 4.03 | 2.61 | 4.58 | 4.92 | Upgrade
|
Other Operating Expenses | 0 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Operating Expenses | 0 | 2.78 | 4.33 | 3.38 | 4.33 | 8.06 | 10.57 | 11.93 | 12.72 | 13.85 | Upgrade
|
Operating Income | 0 | -1.21 | -0.76 | -0.73 | -3.92 | -5.23 | -6.56 | -4 | -12.2 | -14.09 | Upgrade
|
Interest Income | 0 | 0 | 0 | 0.01 | 0.17 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Interest Expense | 0 | 0.2 | 0.45 | 0.45 | 0.22 | 0.6 | 0.89 | 1.16 | 1.21 | 0.01 | Upgrade
|
Other Expense / Income | - | -0.53 | 0 | 2.61 | -0.59 | - | -0.61 | -1 | -1.14 | -0.21 | Upgrade
|
Pretax Income | 0 | -0.88 | -1.21 | -3.77 | -3.84 | -5.82 | -7.39 | -4.99 | -13.21 | -13.9 | Upgrade
|
Income Tax | 0 | 0.2 | 0.45 | 0.18 | 0.47 | -0.14 | 0.55 | 0.83 | 0.94 | 0.01 | Upgrade
|
Net Income | 0 | -1.08 | -1.66 | -3.95 | -3.84 | -5.68 | -7.39 | -4.99 | -13.21 | -13.9 | Upgrade
|
Shares Outstanding (Basic) | - | 57 | 32 | 27 | 21 | 16 | 12 | 11 | 10 | 10 | Upgrade
|
Shares Outstanding (Diluted) | - | 57 | 32 | 27 | 21 | 16 | 12 | 11 | 10 | 10 | Upgrade
|
Shares Change | - | 75.75% | 20.96% | 26.36% | 32.97% | 33.98% | 9.95% | 10.40% | 2.37% | 0.51% | Upgrade
|
EPS (Basic) | - | -0.02 | -0.05 | -0.15 | -0.18 | -0.36 | -0.62 | -0.46 | -1.35 | -1.46 | Upgrade
|
EPS (Diluted) | - | -0.02 | -0.05 | -0.15 | -0.18 | -0.36 | -0.62 | -0.46 | -1.35 | -1.46 | Upgrade
|
Free Cash Flow | 0 | -0.74 | -0.72 | -0.62 | -3.91 | -4.51 | -5.64 | -3.9 | -13.18 | -13.7 | Upgrade
|
Free Cash Flow Per Share | - | -0.01 | -0.02 | -0.02 | -0.18 | -0.28 | -0.47 | -0.36 | -1.35 | -1.43 | Upgrade
|
Gross Margin | - | 22.52% | 99.95% | 99.94% | 100.00% | 95.68% | 89.90% | 92.36% | 69.77% | 7.32% | Upgrade
|
Operating Margin | - | -77.67% | -21.23% | -27.29% | -954.88% | -176.16% | -146.89% | -46.59% | -1624.37% | -11455.28% | Upgrade
|
Profit Margin | - | -69.03% | -46.44% | -148.66% | -937.07% | -191.57% | -165.50% | -58.10% | -1758.85% | -11301.63% | Upgrade
|
Free Cash Flow Margin | - | -47.47% | -20.14% | -23.26% | -953.17% | -152.06% | -126.30% | -45.44% | -1754.86% | -11139.02% | Upgrade
|
EBITDA | 0 | -1.21 | -0.63 | -0.73 | -3.62 | -5.22 | -6.56 | -4 | -12.2 | -13.71 | Upgrade
|
EBITDA Margin | - | -77.67% | -17.73% | -27.29% | -882.68% | -176.03% | -146.84% | -46.56% | -1624.37% | -11143.09% | Upgrade
|
Depreciation & Amortization | 0 | 0.09 | 0.13 | 0.27 | 0.28 | 0.29 | 0.35 | 0.33 | 0.27 | 0.13 | Upgrade
|
EBIT | - | -1.3 | -0.76 | -1 | -3.9 | -5.52 | -6.9 | -4.33 | -12.47 | -13.84 | Upgrade
|
EBIT Margin | - | -83.43% | -21.23% | -37.56% | -950.98% | -185.94% | -154.57% | -50.43% | -1660.85% | -11252.03% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.